We are live on ! Find out more
Dmitry Balyasny

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B Turnover 42.78%
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$3.01B
Cap. Flow %
-3.76%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.95%
2 Technology 12.69%
3 Industrials 10%
4 Consumer Discretionary 7.97%
5 Healthcare 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DJTWW icon
2651
Trump Media & Technology Group Warrants
DJTWW
$521M
$266K ﹤0.01%
83,403
– –
2025 Q4
2 quarters
HTB icon
2652
HomeTrust Bancshares
HTB
$743M
$265K ﹤0.01%
+5,316
New +$246K
2026 Q2
0 quarters
ATAI icon
2653
DELISTED
AtaiBeckley Inc
ATAI
$265K ﹤0.01%
+50,249
New +$212K
2026 Q2
0 quarters
CSGP icon
2654
CoStar Group
CSGP
$12.3B
$265K ﹤0.01%
9,349
+3,023
+48% +$104K
2025 Q4
2 quarters
ORIC icon
2655
Oric Pharmaceuticals
ORIC
$914M
$262K ﹤0.01%
24,201
-499,589
-95% -$4.53M
2024 Q3
7 quarters
THC icon
2656
CALL
Tenet Healthcare
THC
$22.5B
$262K ﹤0.01%
1,400
-1,000
-42% -$184K
2025 Q2
4 quarters
CPT icon
2657
Camden Property Trust
CPT
$11.5B
$261K ﹤0.01%
+2,280
New +$243K
2026 Q2
0 quarters
RBLX icon
2658
Roblox
RBLX
$35.3B
$259K ﹤0.01%
+4,762
New +$237K
2026 Q2
0 quarters
MOV icon
2659
Movado Group
MOV
$692M
$256K ﹤0.01%
+6,523
New +$204K
2026 Q2
0 quarters
PIPR icon
2660
Piper Sandler
PIPR
$4.66B
$256K ﹤0.01%
3,533
-330,993
-99% -$26.8M
2025 Q1
5 quarters
PSEC icon
2661
Prospect Capital
PSEC
$785M
$254K ﹤0.01%
+109,969
New +$271K
2026 Q2
0 quarters
OPLN icon
2662
Openlane
OPLN
$4.17B
$252K ﹤0.01%
+6,120
New +$214K
2026 Q2
0 quarters
CTRN icon
2663
Citi Trends
CTRN
$375M
$252K ﹤0.01%
4,356
-4,012
-48% -$192K
2026 Q1
1 quarter
CTBI icon
2664
Community Trust Bancorp
CTBI
$1.26B
$252K ﹤0.01%
+3,480
New +$232K
2026 Q2
0 quarters
BOW icon
2665
Bowhead Specialty Holdings
BOW
$1.12B
$251K ﹤0.01%
8,384
-132,756
-94% -$3.45M
2024 Q2
8 quarters
BAX icon
2666
Baxter International
BAX
$13.3B
$250K ﹤0.01%
+11,716
New +$218K
2026 Q2
0 quarters
IFS icon
2667
Intercorp Financial Services
IFS
$5.14B
$248K ﹤0.01%
+4,354
New +$216K
2026 Q2
0 quarters
TTAM icon
2668
Titan America SA
TTAM
$2.08B
$248K ﹤0.01%
+13,286
New +$218K
2026 Q2
0 quarters
CRL icon
2669
Charles River Laboratories
CRL
$16.2B
$248K ﹤0.01%
1,093
-10,983
-91% -$1.96M
2024 Q4
6 quarters
DHR icon
2670
PUT
Danaher
DHR
$162B
$248K ﹤0.01%
+1,300
New +$236K
2026 Q2
0 quarters
POET icon
2671
CALL
POET Technologies
POET
$877M
$247K ﹤0.01%
+24,000
New +$261K
2026 Q2
0 quarters
MTRX icon
2672
Matrix Service
MTRX
$271M
$246K ﹤0.01%
+17,932
New +$231K
2026 Q2
0 quarters
MKTX icon
2673
MarketAxess Holdings
MKTX
$5.83B
$244K ﹤0.01%
2,153
-2,032
-49% -$290K
2025 Q4
2 quarters
AEVA icon
2674
Aeva Technologies
AEVA
$767M
$244K ﹤0.01%
+8,499
New +$167K
2026 Q2
0 quarters
IBCP icon
2675
Independent Bank Corp
IBCP
$802M
$243K ﹤0.01%
+6,742
New +$231K
2026 Q2
0 quarters

Similar funds

Dmitry Balyasny's Q2 2026 Portfolio in Review

As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.

  • Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
  • Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.